Optometry News

Bausch + Lomb announced the U.S. launch of Zenlens Echo, a non-prosthetic custom scleral contact lens technology designed for a range of fit needs, including patients with advanced ocular conditions such as corneal degeneration.

In June, retina experts from around the world will convene in Park City, Utah, to discuss ongoing clinical trials, best trial practices and recent data at Clinical Trials at the Summit.

Wellness company HealthyCell has announced the launch of Eye Health, the newest supplement in the company’s MicroGel product line, which is designed to promote visual acuity, protect against oxidative stress and support retinal health.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Sean D. Adrean, MD, discusses data on aflibercept 8 mg vs. aflibercept 2 mg for the treatment of diabetic macular edema at 1 year.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Paulo E. Stanga, MD, explains how the Bionic Eye System provides artificial vision for patients with vision loss due to inherited retinal diseases.

Any doctor seeing patients has had to field questions unrelated to their specialty.

The FDA approved Yesafili and Opuviz as the first interchangeable biosimilars to Eylea, according to a press release from the FDA.

Re-esterified triglyceride omega-3 fatty acid supplementation did not improve symptoms of dry eye disease associated with meibomian gland dysfunction in a small cohort of patients, according to research published in JAMA Ophthalmology.

EyeCRO announced that its Microemulsion Drug Ocular Penetration System, or MiDROPS, demonstrated safety and efficacy in its first clinical application as a topical eye drop vehicle for dry eye disease.

Ophthalmologists can attend interactive sessions, network with colleagues and earn CME credits at this year’s Kiawah Eye, organized by Healio Live.